newsfilter
← Latest News
GlobeNewswire·

Celularity Inc. Announces Receipt of Nasdaq Notification

FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) ("Celularity" or the "Company"), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced